Market Analysis

Mixed Signals for Potential Long-Term Investments as Market Navigates Rate Expectations and Tariffs; AFJK Silent on Recent Growth Drivers, Lennar Faces Post-Earnings Headwinds

Financial Markets

Mixed Signals for Potential Long-Term Investments as Market Navigates Rate Expectations and Tariffs; AFJK Silent on Recent Growth Drivers, Lennar Faces Post-Earnings Headwinds

The stock market experienced a week of cautious optimism and shifting expectations around September 20, 2025, marked by global index gains and evolving views on Federal Reserve interest rate policies. While certain sectors like technology and banking showed strength, the landscape for specific long-term investment opportunities like AFJK and

By MarketMinute
Thirumalai Chemicals Limited: A High-Stakes Bet for Momentum Traders Amidst Mixed Signals

Thirumalai Chemicals Limited

Thirumalai Chemicals Limited: A High-Stakes Bet for Momentum Traders Amidst Mixed Signals

Mumbai, India – September 27, 2025 – Thirumalai Chemicals Limited (NSE: THIRUMALCH) has become a focal point for momentum traders, who are closely monitoring the specialty chemical manufacturer for potential rapid price movements. This heightened interest stems from a confluence of bullish technical indicators suggesting an imminent upward trajectory, even as the

By MarketMinute
Corporate Maneuvers: Glenmark Pharma Declares Dividend Amidst Sector Headwinds, Paushak Announces Stock Split and Bonus Issue

Glenmark Pharmaceuticals

Corporate Maneuvers: Glenmark Pharma Declares Dividend Amidst Sector Headwinds, Paushak Announces Stock Split and Bonus Issue

Mumbai, India – The Indian financial markets have been abuzz with significant corporate actions last week, as two prominent companies, Glenmark Pharmaceuticals (NSE: GLENMARK) and Paushak Ltd. (NSE: PAUSHAK), made headlines with their respective announcements. While Paushak Ltd. moved to enhance shareholder value and liquidity through a stock split and bonus

By MarketMinute